Filing Details
- Accession Number:
- 0001209191-20-026153
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-29 16:14:41
- Reporting Period:
- 2020-04-28
- Accepted Time:
- 2020-04-29 16:14:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1334365 | Yuchun Lee | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-28 | 1,125 | $57.27 | 3,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-28 | 200 | $254.81 | 2,800 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-28 | 240 | $255.79 | 2,560 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-28 | 149 | $257.20 | 2,411 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-28 | 120 | $258.53 | 2,291 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-28 | 120 | $259.61 | 2,171 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-28 | 180 | $260.53 | 1,991 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-28 | 116 | $261.80 | 1,875 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-04-28 | 1,125 | $0.00 | 1,125 | $57.27 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-09-13 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $254.81 (range $254.32 to $255.26).
- Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $255.79 (range $255.40 to $256.14).
- Open market sales reported on this line occurred at a weighted average price of $257.20 (range $256.87 to $257.37).
- Open market sales reported on this line occurred at a weighted average price of $258.53 (range $258.13 to $258.92).
- Open market sales reported on this line occurred at a weighted average price of $259.61 (range $259.28 to $259.94).
- Open market sales reported on this line occurred at a weighted average price of $260.53 (range $260.32 to $260.94).
- Open market sales reported on this line occurred at a weighted average price of $261.80 (range $261.58 to $262.00).
- Fully vested.
Billionaire Hedge Funds
